Act1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition via CXCL9/10-CXCR3-axis in CRC cells and immunosuppression via PD-l/PDL-1axis in CD8+ T cells. Here, TRAF3IP2 is linked to adenocarcinoma.